S
21.18
-1.05 (-4.72%)
| 前收盘价格 | 22.23 |
| 收盘价格 | 22.24 |
| 成交量 | 1,992,273 |
| 平均成交量 (3个月) | 2,958,225 |
| 市值 | 2,223,683,584 |
| 预期市盈率 (P/E Forward) | 5.74 |
| 价格/销量 (P/S) | 0.990 |
| 股市价格/股市净资产 (P/B) | 2.00 |
| 52周波幅 | |
| 利润日期 | 6 May 2026 |
| 营业毛利率 | -11.12% |
| 营业利益率 (TTM) | -40.33% |
| 稀释每股收益 (EPS TTM) | -2.64 |
| 季度收入增长率 (YOY) | 80.20% |
| 季度盈利增长率 (YOY) | 248.40% |
| 总债务/股东权益 (D/E MRQ) | 118.73% |
| 流动比率 (MRQ) | 4.02 |
| 营业现金流 (OCF TTM) | -547.15 M |
| 杠杆自由现金流 (LFCF TTM) | -741.26 M |
| 资产报酬率 (ROA TTM) | -2.19% |
| 股东权益报酬率 (ROE TTM) | -23.61% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Sarepta Therapeutics, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
0.0
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.5 |
| 平均 | 0.00 |
|
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 4.42% |
| 机构持股比例 | 96.33% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 38.00 (Wells Fargo, 79.42%) | 购买 |
| 中 | 21.50 (1.51%) | |
| 低 | 5.00 (HC Wainwright & Co., -76.39%) | 卖出 |
| 平均值 | 21.50 (1.51%) | |
| 总计 | 2 购买, 2 卖出 | |
| 平均价格@调整类型 | 17.97 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Citigroup | 10 Mar 2026 | 9.00 (-57.51%) | 卖出 | 17.66 |
| HC Wainwright & Co. | 02 Mar 2026 | 5.00 (-76.39%) | 卖出 | 16.32 |
| 27 Jan 2026 | 5.00 (-76.39%) | 卖出 | 22.17 | |
| Wells Fargo | 27 Feb 2026 | 38.00 (79.41%) | 购买 | 16.76 |
| Wedbush | 23 Jan 2026 | 34.00 (60.53%) | 购买 | 21.13 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合